The aim of this course is to provide participants with practical guidance on how to design, implement and evaluate HIV prevention and treatment programmes in key populations, primarily men who have sex with men (MSM), people who inject drugs (PWID), female sex workers (FSW) and people in prisons. The course will also outline methods used to estimate the size of key populations.
The course starts with an outline of the current evidence on effectiveness of biological, behavioural and structural HIV prevention strategies in key populations, obtained mainly from systematic reviews and meta-analysis. Participants will be given an opportunity to share their own country-specific experiences in implementation and evaluation of HIV programmes among populations at higher risk of HIV on the first day, and challenges that have been encountered.
The course will further address specific interventions that are effective in HIV prevention and treatment in key populations, along with critical enables required for successful implementation, priority setting process, planning services and target setting process. Presentations on HIV programming in key populations will draw on the WHO Consolidated Guidelines for HIV Prevention, Diagnosis, Treatment and Care for Key Populations and primarily describe health sector interventions such as condom use, pre-exposure prophylaxis (PreP) for MSM and sero-discordant couples, post-exposure prophylaxis (PEP), harm reduction for PWID, different approaches used in HIV testing and counselling, prevention and management of co-infections and co-morbidities and sexual and reproductive health interventions. Participants will also learn which strategies to improve service delivery, such as integration, decentralization and task shifting can improve the accessibility of care.
The next part of the course will present methods of evaluation of HIV programmes, from cross-sectional surveys to randomized trials and other experimental designs. The issues to be addressed include the selection of the study population, sampling, statistical inference and measuring outcomes and impact. Next, the course will focus on design of size estimation studies and the use of size estimations to calculate programme coverage.
The key part of the course is a group work, which consists of development of a protocol that participants will present at the end of the course. Participants can choose the topic of the protocol – either for design and implementation of HIV interventions, evaluation of a programme/interventions or size estimation. While developing the protocol proposals, it is important to take into account specific contextual issues in countries and the heterogeneity of key populations, epidemiological and social context and the current coverage levels with interventions.
Key topics of the course are:
- Current evidence of efficacy and effectiveness of biological, behavioural and structural HIV prevention and treatment interventions in key populations
- Planning and implementing comprehensive HIV programmes in MSM, PWID, FSW and people in prisons
- Methods used to design evaluation studies (cross-sectional studies, cohort studies, randomized control trials, stepped wedge designs, preference trials and randomised consent designs, pre-post intervention designs, etc.) in key populations
- Monitoring and evaluation of ART programmes, including HIV care and treatment indicators (cohort analysis)
- Constructing a cascade of HIV prevention, care and treatment in key populations with examples
- Measuring coverage with HIV interventions using population size estimation methods (census and enumeration, capture-recapture, multiplier method, network scale-up)
The course consists of lectures, exercises and case studies. It is designed to provide participants with practical skills and knowledge in development, implementation and evaluation of HIV interventions in key populations.
An important part of the course is a group or individual work during which participants will develop protocols for design of HIV interventions, evaluation of HIV programmes/ interventions or size estimation studies. Participants are encouraged to work on a protocol which they can later on use in their countries. The protocols will be presented by participants during the final day of the workshop.
Professionals working on planning, implementation and evaluation of HIV prevention and treatment programmes.
Course lecturers and facilitators:
- Professor George W. Rutherford, MD, Global Health Sciences, University of California, San Francisco, USA
- Associate professor Ivana Bozicevic, MD, MSc, DrPH, WHO Collaborating Centre for HIV Strategic Information, School of Medicine, University of Zagreb
- Zoran Dominković, WHO Collaborating Centre for HIV Strategic Information, School of Medicine, University of Zagreb
Lucija Šikić, WHO Collaborating Centre for HIV Strategic Information
Duration and site
The course takes place in five days, from 26 – 30 June 2017 at the WHO Collaborating Centre for HIV Strategic Information in Zagreb, Croatia.
The course fee is 950 USD and includes training materials and lunch and coffee/tea breaks during the course.